Why have we decided the fair price of the drug is based on ICER analysis rather than something like below?
Cost of devel/# of courses over patent life + manuf cost + reasonable profit +/- time value of money
@VPrasadMDMPH @drjohnm @AnkurFactorialhttps://twitter.com/CMichaelGibson/status/1257381129751007233 …
Can I just say that having an economic institute with the term ICER talking about cost-efficacy is extraordinarily confusing Also, because of capitalism I would assume. They charge what the market will bear
-
-
Actually, drug pricing seems to be driven in large part by anti-competitive forces like patents and high regulatory barriers. In many cases they are necessary, but hard to say they are market driven.
-
I was being a bit glib
That being said, the only people it really serves if the pricing mechanics become less opaque is the patients, so I suspect the prices won't come down significantly unless the US govt takes action - Show replies
New conversation -
Loading seems to be taking a while.
Twitter may be over capacity or experiencing a momentary hiccup. Try again or visit Twitter Status for more information.